BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7911871)

  • 41. Acute myeloblastic leukemia with a pericentric inversion of chromosome 6 in a child with Down syndrome.
    Shekhter-Levin S; Mirro J; Penchansky L; Sherer ME; Wald N; Gollin SM
    Cancer Genet Cytogenet; 1994 Apr; 73(2):157-60. PubMed ID: 7986260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of an inversion 16 coexisting with an isochromosome 22q by in situ hybridization in a case of childhood AML M4e.
    Gad SG; Callen DF; Kuss B; Downing JR; Behm F; Head D; Ribeiro RC; Raimondi SC
    Leukemia; 1993 Oct; 7(10):1658-62. PubMed ID: 8412329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deletion of chromosome arm 15q in a case of minimally differentiated hypoplastic AML-M0.
    Fujieda A; Masuya M; Kitano S; Miyazaki K; Yazaki A; Sugimoto Y; Usui E; Miyata E; Shibasaki T; Yamamura K; Ohishi K; Nishii K; Nakase K; Takeuchi T; Katayama N
    Cancer Genet Cytogenet; 2008 Jul; 184(1):57-61. PubMed ID: 18558291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deletion 15q as the sole abnormality in acute myeloid leukemia: report of three cases and review of the literature.
    Lu G; Yin CC; Medeiros LJ; Abruzzo LV
    Cancer Genet Cytogenet; 2009 Jan; 188(2):118-23. PubMed ID: 19100517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deletion of 3'CBFbeta in an inv(16)(p13.lq22) ascertained by fluorescence in situ hybridization and reverse-transcriptase polymerase chain reaction.
    Hung D; St Heaps L; Benson W; Mirochnik O; Sharma P; Smith A
    Cancer Genet Cytogenet; 2007 Jan; 172(1):92-4. PubMed ID: 17175390
    [No Abstract]   [Full Text] [Related]  

  • 46. PRIMA-1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion.
    Nahi H; Merup M; Lehmann S; Bengtzen S; Möllgård L; Selivanova G; Wiman KG; Paul C
    Br J Haematol; 2006 Jan; 132(2):230-6. PubMed ID: 16398657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Crizotinib resistance in acute myeloid leukemia with inv(2)(p23q13)/RAN binding protein 2 (RANBP2) anaplastic lymphoma kinase (ALK) fusion and monosomy 7.
    Takeoka K; Okumura A; Maesako Y; Akasaka T; Ohno H
    Cancer Genet; 2015 Mar; 208(3):85-90. PubMed ID: 25766836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
    Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
    Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
    Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
    Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.
    Freireich EJ; Cork A; Stass SA; McCredie KB; Keating MJ; Estey EH; Kantarjian HM; Trujillo JM
    Leukemia; 1992 Jun; 6(6):500-6. PubMed ID: 1602788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute myeloid leukemia presenting in a mother and daughter pair with the identical acquired karyotypic abnormality consisting of inversion 3q21q26 and monosomy 7: a review of possible mechanisms.
    Lawrie A; Stevenson DA; Doig TN; Vickers MA; Culligan DJ
    Cancer Genet; 2012 Nov; 205(11):599-602. PubMed ID: 23064135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of trisomy 22 and inversion 16 in acute myeloid leukemia].
    Zhou HF; Li JY; Pan JL; Qiu HR; Chen LJ; Hu JY; Shen YF; Xu W; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):11-4. PubMed ID: 17649718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 3'CBFbeta deletion associated with inv(16) in acute myeloid leukemia.
    Kelly J; Foot NJ; Conneally E; Enright H; Humphreys M; Saunders K; Neat MJ
    Cancer Genet Cytogenet; 2005 Oct; 162(2):122-6. PubMed ID: 16213359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia: a case report of a 9-month-old infant.
    Ohga S; Ishii E; Fujioka K; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1987 Feb; 50(1):114-8. PubMed ID: 3473882
    [No Abstract]   [Full Text] [Related]  

  • 56. Inversion of chromosome 16 in bone marrow eosinophils of acute myelomonocytic leukemia (M4) with eosinophilia.
    Nakamura H; Sadamori N; Tagawa M; Sasagawa I; Itoyama T; Yao E; Ichimaru M
    Cancer Genet Cytogenet; 1987 Dec; 29(2):327-30. PubMed ID: 3479239
    [No Abstract]   [Full Text] [Related]  

  • 57. Detection of inv(16) and t(16;16) by fluorescence in situ hybridization in acute myeloid leukemia M4Eo.
    Hernández JM; González MB; Granada I; Gutiérrez N; Chillón C; Ramos F; Ribera JM; González M; Feliu E; San Miguel J
    Haematologica; 2000 May; 85(5):481-5. PubMed ID: 10800163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
    Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
    Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Complex additional chromosomal abnormalities of del(5q), del(7q), and +22 in a patient with acute myelomonocytic leukemia carrying inv(16)].
    Nakaya A; Fujita H; Tachibana T; Takemura S; Ishigatsubo Y
    Rinsho Ketsueki; 2004 Sep; 45(9):1061-3. PubMed ID: 15510837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
    Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
    Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.